Management of patients with refractory immune thrombocytopenic purpura
- 1 August 2006
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (8) , 1664-1672
- https://doi.org/10.1111/j.1538-7836.2006.02013.x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesAmerican Journal of Hematology, 2004
- Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITPBlood, 2004
- Initial management of immune thrombocytopenic purpura in adults: A randomized controlled trial comparing intermittent anti-D with routine careAmerican Journal of Hematology, 2003
- Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose DexamethasoneNew England Journal of Medicine, 2003
- Immune Thrombocytopenic Purpura — Let the Treatment Fit the PatientNew England Journal of Medicine, 2003
- Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBritish Journal of Haematology, 2003
- Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.Journal of Clinical Investigation, 1987
- Thrombocytopenia after Treatment with DanazolNew England Journal of Medicine, 1986
- Idiopathic thrombocytopenic purpura in the elderlyThe Lancet Healthy Longevity, 1978
- SPLENECTOMY AND SUBSEQUENT MORTALITY IN VETERANS OF THE 1939-45 WARThe Lancet, 1977